Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987

Blood

Volumn 73, Issue 1, 1989, Pages 47-56

  Tubiana, M ^a   Henry Amar, M ^a   Carde, P ^a   Burgers, J M V ^a   Hayat, M ^a   Van Der Schueren, E ^a   Noordijk, E M ^a   Tanguy, A ^a   Meerwaldt, J H ^a   Thomas, J ^a   De Pauw, B ^a   Monconduit, M ^a   Cosset, J M ^a   Somers, R ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

CANCER STAGING; HODGKIN DISEASE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0024501372     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v73.1.47.bloodjournal73147     Document Type: Article

References (0)